Lung Cancer

Treatment for Cancer Needs To Be Tailored to Patient

Published in Cancer Weekly, November 2nd, 1998

Physicians treating patients with locally advanced, non-small-cell lung cancer (NSCLC) should consider a number of factors when choosing appropriate therapy, rather than applying the same treatment to all such patients, a U.S. study recommended.

The analysis of several Radiation Therapy Oncology Group (RTOG) multi-center studies was presented at the Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), held in Phoenix, Arizona, October 25-29, 1998.

In reviewing the cases of nearly 1,000 patients with inoperable, locally advanced NSCLC treated with radiation with or without chemotherapy, the researchers looked at...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1998-11-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry